pathwayhealthadmin

TORONTO, ON, October 31, 2022 – Pathway Health Corp. (TSXV: PHC) (Frankfurt:  KL1) (formerly Colson Capital Corp.) ("Pathway" or the "Company"), an integrated healthcare company that provides products and services to patients suffering from chronic pain and related conditions, is pleased to announce that it has signed a Collaboration Agreement (the “Agreement”) with Sunshine Drugs, [...]

TORONTO, ON, October 27, 2022 – Pathway Health Corp. (TSXV: PHC) (Frankfurt:  KL1) (formerly Colson Capital Corp.) ("Pathway" or the "Company"), an integrated healthcare company that provides products and services to patients suffering from chronic pain and related conditions, is pleased to announce that it has entered into an arm’s length asset purchase agreement to [...]

TORONTO, ON, September 29, 2022 – Pathway Health Corp. (TSXV: PHC) (Frankfurt:  KL1) (formerly Colson Capital Corp.) ("Pathway" or the "Company"), an integrated healthcare company that provides products and services to patients suffering from chronic pain and related conditions, announces the grant of 3,505,593 stock options to directors, officers, employees and consultants on September 28, [...]

Second quarter 2022 revenues came in at $2.8 million and were up approximately 9% sequentially over the first quarter 2022. The Company entered into a $1.0 million bridge loan in the second quarter that rolled into a $3.5 million revolving line of credit subsequent to quarter end. The Company has applied for a non-possession sales [...]

TORONTO, ON, August 24, 2022 – Pathway Health Corp. (TSXV: PHC) (Frankfurt:  KL1) ("Pathway" or the "Company") is pleased to announce the appointment of Mr. Mark Goldhar to the board of directors of the Company. Mr. Goldhar will also join the Audit and the Compensation and Governance Committees. Mr. Goldhar has co-founded 12 companies, 4 of [...]

Three years ago, the government appointed the Science Advisory Committee to recommend guidelines to assist Health Canada in the development of regulations to permit the sales of CBD based Cannabis Health Products (CHPs) in an over the counter (OTC) setting. After much anticipation, the committee announced their recommendation last Thursday. We highlight some key points [...]

TORONTO, ON, August 3, 2022 – Pathway Health Corp. (TSXV: PHC) (Frankfurt:  KL1) ("Pathway" or the "Company"), an integrated healthcare company that provides products and services to patients suffering from chronic pain and related conditions, announced today that Mr. Michael Steele has resigned from the Board of Directors of the Company. “Michael has been a highly valued and [...]

TORONTO, ON, July 29, 2022 – Pathway Health Corp. (TSXV: PHC) (Frankfurt: KL1) ("Pathway" or the "Company") announces that it has entered into an agreement (the “Credit Agreement”) with the Company’s largest indirect beneficial shareholder Avonlea-Drewry Holdings Inc. (the "Lender") to establish a $3.5 million credit facility (the “Facility”) (inclusive of all amounts advanced under [...]

Dear Shareholders, Pathway Health continues to be committed to improving the quality of life for patients suffering from chronic pain and related conditions. At Pathway, we believe medical cannabis will have a role to play in the management of chronic pain, harm reduction for opiate reliance, and will be important to Pathway’s future growth plans. [...]

CALGARY, AB, May 27, 2022 /CNW/ - Pathway Health Corp. (TSXV: PHC) ("Pathway" or the "Company") announces that it has issued a secured promissory grid note (the "Bridge Note") to Avonlea-Drewry Holdings Inc. (the "Lender") for available proceeds to the Corporation of up to Cdn.$1,000,000 (the "Loan"). The Loan has a term of 90 days from the date of [...]